Regulatory and Economical Aspects in Virology

The vaccine technology market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%.

Major factors driving growth of vaccine technology market include rising prevalence of diseases, increasing government initiatives for expanding immunization across the globe, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans.

  • Virus Safety Risk Assessment
  • Virus Clearance Technologies to Address Current Needs in Bio-manufacturing Facility Control and Protection
  • Latest Developments in the Prophylactic and the Therapeutic Segment
  • Optimizing Pre-clinical & Clinical Trials Performance
  • Exploring the Future Potential of the Vaccine Market and Achieving Vaccine Manufacturing Excellence

Related Conference of Regulatory and Economical Aspects in Virology

March 18-19, 2024

53rd World Congress on Microbiology

Zurich, Switzerland
May 09-10, 2024

16th International Virology Summit

Barcelona, Spain
June 10-11, 2024

5th International Conference on Molecular Microbiology

Barcelona, Spain

Regulatory and Economical Aspects in Virology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in